Sodium glucose cotransporter-2 inhibitor use associated with increased risk of diabetic ketoacidosis
1. The use of sodium-glucose cotransporter-2 (SGLT-2i) increased study participants’ risk of diabetic ketoacidosis (DKA) hospital presentations when compared to ...